27Sep 2017

SIX YEARS FOLLOW-UP OF LOW-LEVEL LASER THERAPY (LLLT) IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (AMD).

  • Chair of Emergency Medicine, Department of ophthalmology, Medical University ? Sofia, Bulgaria.
  • Institute of Electronics, Bulgarian Academy of Sciences.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Purpose: The objective of this study is to examine long-term effects of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD). Methods: The research was implemented for a period of six years. For LLLT, a He-Ne Laser with continuous emission at 633 nm (01 mW/cm2) was used in patients with AMD of all stages (dry to wet exudative forms were included). In total, 33 patients (16 men and 17 women - 66 eyes) with AMD of various stages and a mean age of 68.7 ?4.2 years were included in the study. Progressive, exudative AMD was diagnosed in 8 eyes. 58 eyes had drusen or were depigmented. Laser radiation was applied transpupillary for 6 times for 3 min once in two days to the macula. 22 patients with AMD (44 eyes) were randomly selected to receive mock treatment (control group 10 men and 12 women with a mean age of 69.3? 4.8 years). Visual acuity was followed for a 6-year period. The perimetry and Amsler test was used to screen central scotomas. Fluorescein angiography of AMD and control groups was examined. Results: Visual acuity remained unchanged in all patients in the control group. There was a statistically significant increase in visual acuity (p<0.001, end of study versus baseline) for AMD patients for the period of 6 years after the treatment. The edema and hemorrhage in the patients with progressive, exudative AMD significantly decreased. No side effects were observed during the therapy. The prevalence of metamorphopsia, scotoma in AMD group was reduced. Conclusion: In conclusion, this study shows that LLLT may be a novel long-lasting therapeutic option for both forms of AMD. This is highly effective treatment that improves visual acuity for a long time.


  1. Raul Velez-Montoya, Scott C. N. Oliver, Jeffrey L. Olson, Stuart L. Fine, Hugo Quiroz-Mercado, Naresh Mandava. Current Knowledge And Trends In Age-Related Macular Degeneration. Retina 2014, 34:3, 423-441. A.P.
  2. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 2003; 48, 257?293.
  3. Hooper, C.Y., and Guymer, R.H. New treatments inage-related macular degeneration. Clin. Experiment. Ophthalmol. 2003; 31, 376?391.
  4. AREDS Report No. 8 (Age-Related Eye Disease Study Research Group). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins Cand E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch. Ophthalmol. 2001; 119, 1417? 1436.
  5. Holz, F.G., and Miller, D.W. Pharmacological therapy for age-related macular degeneration. Current developments and perspectives. Ophthalmologe. 2003; 100, 97?103.
  6. Holz, F.G., and Pauleikhoff, D. Age-related macular degeneration. 2. Therapeutic approaches. Ophthalmologe. 1996; 93, 483?506.
  7. Graham F. Merry, Marion R. Munk, Robert S. Dotson, Michael G. Walker, Robert G. Devenyi. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry? age-related macular degeneration.? Acta Ophthalmologica 2017; 95:4, e270-e277.
  8. Ivandic BT1, Ivandic T. Low-level laser therapy improves vision in patients with age-related macular degeneration. Photomed Laser Surg.2008 Jun;26(3):241-5. doi: 10.1089/pho.2007.2.
  9. Koev K Borisova K. Avramov L. Two year follow-up of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD) Acta ophtalmologica scandinavica , 2012, volum 90 issue Supl s249 p. 67.
  10. Aimbire F, Albertini R, Pacheco MT, et Posten W, Wrone DA, Dover JS, Arndt KA, Silapunt S, Alam M. Low-level laser therapy for wound healing: mechanism and efficacy. Dermatol Surg 2005; 31: 334-340.
  11. de Carvalho PT, Mazzer N, Barbieri CH, Siqueira JFR. Morphometric analysis of the percentage of collagen and number of macrophages highlighted by immunohistochemistry, in cutaneous wound in diabetic and non-diabetics rats treated through He-Ne laser. Lasers Med Sci 2003; 18 (Suppl 1): S0167 (Abstract).
  12. de Carvalho PT, Mazzer N, dos Reis FA, Belchior AC, Silva IS. Analysis of the influence of low-power He-Ne laser on the healing of skin wounds in diabetic and non-diabetic rats. Acta Cir Bras 2006; 21: 177-183.
  13. Amaral AC, Parizotto NA, Salvini TF. Dose-dependency of low-energy HeNe laser effect in regeneration of skeletal muscle in mice. Lasers Med Sci 2001; 16: 44-51.
  14. Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response. 2009; 7(4): 358-83.
  15. Mozhgan Rezaei Kanavi, Faraj Tabeie, Farzin Sahebjam, Nima Poursani, Nazanin Jahanbakhsh, Pouya Paymanpour, Sasha AfsarAski. . Short-term effects of extremely low-frequency pulsed electromagnetic field and pulsed low-level laser therapy on rabbit model of corneal alkali burn. Experimental Eye Research 2016, 145, 216-223.
  16. Volkmar Kreisel. . Low-Level-Laser Therapie Bei Altersabh?ngiger Makula Degeneration. Akupunktur & Aurikulomedizin 2016 42:2, 11-16.
  17. Ann D. Liebert, Roberta T. Chow, Brian T. Bicknell, Euahna Varigos. . Neuroprotective Effects against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the Cytoskeleton. Journal of Experimental Neuroscience 2016, 10, JEN.S33444.
  18. Sivaraman Purushothuman, Daniel M. Johnstone, Charith Nandasena, Janet van Eersel, Lars M. Ittner, John Mitrofanis, Jonathan Stone. Near infrared light mitigates cerebellar pathology in transgenic mouse models of dementia. Neuroscience Letters 2015; 591, 155-159.
  19. M. Johnstone, N. el Massri, C. Moro, S. Spana, X.S. Wang, N. Torres, C. Chabrol, X. De Jaeger, F. Reinhart, S. Purushothuman, A.-L. Benabid, J. Stone, J. Mitrofanis. Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism ? An abscopal neuroprotective effect. Neuroscience 2014, 274, 93-101.
  20. Ivandic Boris T., Ivandic Tomislav. Low-Level Laser Therapy Improves Vision in a Patient with Retinitis Pigmentosa. Photomedicine and Laser Surgery 2014, 32:3, 181-184.
  21. Boaz Kim, Alice Brandli, John Mitrofanis, Jonathan Stone, Sivaraman Purushothuman, Daniel M. Johnston. Remote tissue conditioning ? An emerging approach for inducing body-wide protection against diseases of ageing. Ageing Research Reviews 2017, 37, 69-78.
  22. Mohammed A. Hadis, Paul R. Cooper, Michael R. Milward, Patricia. C. Gorecki, Edward Tarte, James Churm, William M. Palin. Development and application of LED arrays for use in phototherapy research. Journal of Biophotonics 2017 Chapter 54 Bright New World 1093-1106.
  23. Koev Kr., Tanev V., Rousseva, A. Mihova Comparative Study on the Effect of He-Ne Laser Radiation and Polarized Monochromatic Light on the Changes? of the Cornea after Chemical Burning. Proceedings of SPIE-The? internacional Society for Optical Engineering vol . 2007; 5830, 2005, p. 459-462.
  24. Hawkins, N. Houreld, H. Abrahamse, ?Low level laser therapy (LLLT) as an effective therapeutic modality for delayed wound healing?, Ann. NY Acad. Sci., Vol. 1056, 486-493 (2005).
  25. Reddy GK. Photobiological basis and clinical role of low-intensity lasers in biology and medicine. J Clin Laser Med Surg 2004; 22: 141-150.
  26. Medrado AR, Pugliese LS, Reis SR, Andrade ZA. Influence of low level laser therapy on wound healing and its biological action upon myofibroblasts. Lasers Surg Med 2003; 32: 239-244.
  27. Maiya GA, Kumar P, Rao L. Effect of low intensity helium-neon (He-Ne) laser irradiation on diabetic wound healing dynamics. Photomed Laser Surg 2005; 23: 187-190.
  28. Florian Reinhart, Nabil El Massri, Claude Chabrol, Celine Cretallaz, Daniel M. Johnstone, Napoleon Torres, Fannie Darlot, Thomas Costecalde, Jonathan Stone, John Mitrofanis, Alim-Louis Benabid, C?cile Moro. Intracranial application of nearinfrared light in a hemi-parkinsonian rat model: the impact on behavior and cell survival. Journal of Neurosurgery 2016; 124:6, 1829-1841.
  29. Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response. 2009; 7(4): 358-83.
  30. SM Safavi, B Kazemi, M Esmaeili, A Fallah. Effects of low-level He?Ne laser irradiation on the gene expression of IL-1β, TNF-α, IFN-γ, TGF-β, bFGF, and PDGF in rat's gingiva. Lasers in Medical Science2008, Volume 23, Issue?3, pp 331?335 |
  31. Кoev K. E. Borisova, L. Avramov He-Ne low level laser therapeutic applications for treatment of corneal trauma Proceedings of SPIE-The internacional Society for Optical Engineering 2011, vol 7747 ,p 11-1 -11-5

[Krassimir Koev, Latchezar Avramov and Ekaterina Borissova. (2017); SIX YEARS FOLLOW-UP OF LOW-LEVEL LASER THERAPY (LLLT) IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION (AMD). Int. J. of Adv. Res. 5 (Sep). 1428-1432] (ISSN 2320-5407). www.journalijar.com


Assoc. professor Krassimir Koev
Medical University Sofia Bulgaria

DOI:


Article DOI: 10.21474/IJAR01/5463      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5463